CCP III Cayman GP Ltd.

Average Profitability
44.11%
Insider Buys Quantity
20
Insider Buys Sum
$14.79M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of CCP III Cayman GP Ltd.

The largest purchase of all time was on 2022-11-30 and amounted to 184865 shares of GoHealth, Inc. for $2.51M.

Biography of CCP III Cayman GP Ltd.

No biography is available at this moment.

2022-12-13PurchaseGoHealth, Inc.
GOCO
director
48,874
0.5466%
$16.91$826,592-12.56%
2022-12-12PurchaseGoHealth, Inc.
GOCO
director
57,257
0.6237%
$15.56$890,966-7.07%
2022-12-09PurchaseGoHealth, Inc.
GOCO
director
60,526
0.7143%
$14.76$893,280+6.4%
2022-12-08PurchaseGoHealth, Inc.
GOCO
director
24,743
0.2744%
$13.94$344,879+5.84%
2022-12-07PurchaseGoHealth, Inc.
GOCO
director
83,659
0.8735%
$13.02$1.09M+6.67%
2022-12-06PurchaseGoHealth, Inc.
GOCO
director
8,547
0.0942%
$11.32$96,730+29.48%
2022-12-05PurchaseGoHealth, Inc.
GOCO
director
17,626
0.2049%
$12.11$213,476+27.71%
2022-12-02PurchaseGoHealth, Inc.
GOCO
director
22,890
0.2527%
$12.16$278,251+20.84%
2022-12-01PurchaseGoHealth, Inc.
GOCO
director
28,400
0.3063%
$11.38$323,158+26.1%
2022-11-30PurchaseGoHealth, Inc.
GOCO
director
184,865
2.1688%
$13.57$2.51M+15.04%
2022-11-29PurchaseGoHealth, Inc.
GOCO
director
83,364
0.9614%
$11.80$983,483+30.04%
2022-11-28PurchaseGoHealth, Inc.
GOCO
director
38,519
0.4189%
$10.05$387,128+43.94%
2022-11-25PurchaseGoHealth, Inc.
GOCO
director
8,811
0.0975%
$9.03$79,538+63.14%
2022-11-23PurchaseGoHealth, Inc.
GOCO
director
27,602
0.3126%
$9.10$251,115+65.67%
2022-11-22PurchaseGoHealth, Inc.
GOCO
director
55,613
0.5876%
$8.32$462,549+68.98%
2022-11-21PurchaseGoHealth, Inc.
GOCO
director
61,334
0.6764%
$7.92$485,555+85.32%
2022-11-18PurchaseGoHealth, Inc.
GOCO
director
49,447
0.6134%
$7.75$383,028+113.11%
2022-11-17PurchaseGoHealth, Inc.
GOCO
director
2.72M
1.8409%
$0.56$1.52M+60.81%
2022-11-16PurchaseGoHealth, Inc.
GOCO
director
3.37M
2.4701%
$0.48$1.62M+103.47%
2022-11-15PurchaseGoHealth, Inc.
GOCO
director
3M
1.9972%
$0.39$1.16M+129.2%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.